Pola Pengobatan Covid-19 pada Pasien Komorbid di RSUD dr. La Palaloi: The Pattern of Treatment for Covid19 in Comorbid Patients at the dr. La Palaloi Hospital

Dwi Fitrah Wahyuni (Program Studi DIII Farmasi, Sekolah Tinggi Ilmu Kesehatan Salewangang Maros)
An Nisaa Nurzak (Program Studi D-III Farmasi, Stikes Salewangang Maros, Sulawesi Selatan, Indonesia)
Arifuddin Yunus (Program Studi D-III Farmasi, Stikes Salewangang Maros, Sulawesi Selatan, Indonesia)
Nabilah Baharuddin (Sekolah Tinggi Ilmu Keshatan Salewangang Maros)
Sitti Nur Intang (Program Studi DIII Kebidanan, Sekolah Tinggi Ilmu Kesehatan Salewangang Maros)

Jurnal Sains dan Kesehatan
Vol. 4 No. 5 (2022): J. Sains Kes.

As stated by the World Health Organization (WHO) as a global pandemic on March 11, 2020, Coronavirus Disease 2019 (Covid-19), a disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), [1]. For suspected and confirmed Covid-19 patients with mild symptoms, the use of antibiotic drugs is not recommended, both for therapy and prevention [2] .After WHO declared Covid-19 a global pandemic, RSUD dr. La Palaloi is one of the hospitals appointed by the government as a referral hospital for handling Covid-19 in Maros district, South Sulawesi. Comorbidity is one of the factors that causes the mortality rate in patients infected with Covid-19 to increase. The purpose of this study was to describe the pattern of prescribing Covid-19 drugs for comorbid patients. The research method used is a retrospective research method to determine the pattern of Covid-19 treatment with comorbid patients at dr. La Palaloi. The most common comorbidity is hypertension. The most antibiotics given to Covid-19 patients were Azithromycin and the most Antibiotics were Oseltamivir. Treatment for the first Covid-19 patient was given antibiotics and antivirals. Treatment for antihypertensives is the CCB group, for the treatment of diabetes is insulin, and for the treatment of bronchopneumonia, antibiotics are given.